diazoxide has been researched along with Pancreatic Insufficiency in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Background Congenital hyperinsulinism (CH) is the most frequent cause of persistent hypoglycemia in the newborn." | 1.56 | Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism. ( Argente, J; Celaya, P; Cilleruelo, ML; Golmayo, L; Güemes, M; Gutiérrez, C; Lacámara, N; Martínez-Badás, I; Ros-Pérez, P, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ros-Pérez, P | 1 |
| Golmayo, L | 1 |
| Cilleruelo, ML | 1 |
| Gutiérrez, C | 1 |
| Celaya, P | 1 |
| Lacámara, N | 1 |
| Martínez-Badás, I | 1 |
| Güemes, M | 1 |
| Argente, J | 1 |
1 other study available for diazoxide and Pancreatic Insufficiency
| Article | Year |
|---|---|
Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Diazoxide; Exocrine Pancreatic Insufficiency; Hemorrhage; Humans; Infant | 2020 |